• Citryll, Lonza Enter Manufacturing Partnership contractpharma
    September 12, 2019
    The Netherlands-based biotech Citryll and contract development and manufacturing organization (CDMO) Lonza have entered a partnership to develop and manufacture Citryll’s tACPA therapeutic antibody CIT-013.
PharmaSources Customer Service